Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
The prescription of generic drugs represents one of the main cost-containment strategies of health systems, aimed at reducing pharmaceutical expenditure. In this context, most regulatory authorities encourage or obligate dispensing generic drugs because they are far less expensive than their brand-name alternatives. However, drug substitution can be critical in particular situations, such as the use of drugs with a narrow therapeutic index (NTI). Moreover, generics cannot automatically be considered bioequivalent with each other due to the biocreep phenomenon. In Italy, the regulatory authority has established the Transparency Lists which include the medications that will be automatically substituted for brand-name drugs, except in exceptional cases. This is a useful tool to guide prescribers and guarantee pharmaceutical sustainability, but it does not consider the biocreep phenomenon..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Healthcare - 10(2022), 8, p 1392 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lucia Gozzo [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biocreep |
|---|
| doi: |
10.3390/healthcare10081392 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ030389437 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ030389437 | ||
| 003 | DE-627 | ||
| 005 | 20240414135232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/healthcare10081392 |2 doi | |
| 035 | |a (DE-627)DOAJ030389437 | ||
| 035 | |a (DE-599)DOAJ1578ec33eb1743b6a23aa3bf1300ef82 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Lucia Gozzo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The prescription of generic drugs represents one of the main cost-containment strategies of health systems, aimed at reducing pharmaceutical expenditure. In this context, most regulatory authorities encourage or obligate dispensing generic drugs because they are far less expensive than their brand-name alternatives. However, drug substitution can be critical in particular situations, such as the use of drugs with a narrow therapeutic index (NTI). Moreover, generics cannot automatically be considered bioequivalent with each other due to the biocreep phenomenon. In Italy, the regulatory authority has established the Transparency Lists which include the medications that will be automatically substituted for brand-name drugs, except in exceptional cases. This is a useful tool to guide prescribers and guarantee pharmaceutical sustainability, but it does not consider the biocreep phenomenon. | ||
| 650 | 4 | |a generics | |
| 650 | 4 | |a bioequivalence | |
| 650 | 4 | |a substitution | |
| 650 | 4 | |a biocreep | |
| 650 | 4 | |a narrow therapeutic index drugs | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Filippo Caraci |e verfasserin |4 aut | |
| 700 | 0 | |a Filippo Drago |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Healthcare |d MDPI AG, 2013 |g 10(2022), 8, p 1392 |w (DE-627)DOAJ000006815 |x 22279032 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:8, p 1392 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/healthcare10081392 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/1578ec33eb1743b6a23aa3bf1300ef82 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2227-9032/10/8/1392 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2227-9032 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |e 8, p 1392 | ||